| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +3.13M | 91.3% | $192.54 | +$603M |
| Sells | 8 | -298K | 8.7% | $243.13 | -$72.3M |
| Net | -7 | +2.83M | 82.6% | +$530M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Baker Bros. Advisors Lp | Director | $1.15B | +$603M | +110% | Jun 25, 2024 |
| Rebecca Taub | Pres., R&D, and CMO, Director | $278M | -$18.7M | -6.29% | Apr 8, 2024 |
| Paul A. Friedman | Director | $236M | -$24.5M | -9.4% | Jun 25, 2024 |
| Fred B. Craves | Director | $110M | -$4.79M | -4.17% | Jun 25, 2024 |
| William John Sibold | President and CEO, Director | $18.2M | Jan 23, 2024 | ||
| Alex G. Howarth | Chief Financial Officer | $5.74M | Jan 23, 2024 | ||
| Brian J. Lynch | SVP and General Counsel | $5.33M | -$2.03M | -27.6% | Jan 23, 2024 |
| Carole Huntsman | Chief Commercial Officer | $3.69M | Jan 23, 2024 | ||
| Remy Sukhija | Chief Commercial Officer | $3.66M | Jan 16, 2023 | ||
| Richard S. Levy | Director | $3.08M | -$2.83M | -47.9% | Jun 25, 2024 |
| Shannon T. Kelley | General Counsel | $2.23M | Aug 15, 2024 | ||
| Mardi Dier | SVP and CFO | $2.16M | Mar 11, 2024 | ||
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | $1.89M | -$3.13M | -62.4% | Jun 14, 2024 |
| James M. Daly | Director | $535K | -$8.22M | -93.9% | Jun 25, 2024 |
| Kenneth Bate | Director | $535K | -$8.21M | -93.9% | Jun 25, 2024 |
| Bay City Capital Llc | 10%+ Owner | $308K | Dec 3, 2021 | ||
| Raymond Cheong | Director | Jun 15, 2023 | |||
| Keith R. Gollust | Director | Jun 16, 2022 | |||
| David Milligan | Director | Jun 16, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|